Elevate Your Antibody with Composite Human Antibody™ (CHAb) Technology

Abzena’s CHAb technology goes beyond traditional CDR grafting to deliver truly humanized antibodies that retain high affinity, exhibit robust manufacturability, and minimize unwanted responses. Our approach combines smart sequence design—powered by iTope-AI analysis and structural modeling—with targeted liability removal, ensuring your therapeutic candidate maintains essential function while meeting the quality standards required for clinical success.

Ready to See Your Antibody Thrive?
Download the CHAb info sheet to understand how Abzena’s proven humanization platform and extensive development services support a seamless path from concept to clinic.